NCT00077012View on ClinicalTrials.gov

Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2003

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

QLT0074

DRUG

Photodynamic therapy

Trial Locations (7)

20037

George Washington University Medical Center, Washington D.C.

29572

Carolina Urologic Research Center, Myrtle Beach

34652

Advanced Research Institute Inc, New Port Richey

75216

North Texas Veteran Affairs Health Care System, Dallas

94108

Raymond Fay, MD, Inc, San Francisco

V5Z 3J5

The Prostate Centre at Vancouver General Hospital, Vancouver

H3A 1A1

Royal Victoria Hospital, Montreal

All Listed Sponsors
lead

QLT Inc.

INDUSTRY

NCT00077012 - Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter